{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:44:18Z","timestamp":1791225858404,"version":"4.1.0"},"reference-count":307,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"China-Australia Centre for Health Sciences Research","award":["2016GJ01"],"award-info":[{"award-number":["2016GJ01"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jconrel.2017.09.001","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T01:31:24Z","timestamp":1504661484000},"page":"364-389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":373,"special_numbering":"C","title":["Progress in brain targeting drug delivery system by nasal route"],"prefix":"10.1016","volume":"268","author":[{"given":"Abdur Rauf","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengrui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Wasim","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxi","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.09.001_bb0005","unstructured":"BrainFacts.org, The Blood Brain Barrier. http:\/\/www.brainfacts.org\/brainbasics\/neuroanatomy\/articles\/2014\/blood-brain-barrier."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","article-title":"Nanoparticles for direct nose-to-brain delivery of drugs","volume":"379","author":"Mistry","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","article-title":"Transport of drug from nasal cavity to the central nervous system","volume":"11","author":"Illum","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0025","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/cancers5031020","article-title":"Formulation for intranasal delivery of pharmacological agents to combat brain disease: a new opportunity to tackle GBM?","volume":"5","author":"Woensel","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0030","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1749-6632.1986.tb27155.x","article-title":"Tight-junctional modification as the basis of osmotic opening of the blood-brain barrier","volume":"481","author":"Rapoport","year":"1986","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11060-010-0466-4","article-title":"Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy","volume":"104","author":"Joshi","year":"2011","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/pharmaceutics7030175","article-title":"Neurosurgical techniques for disruption of the blood-brain barrier for glioblastoma treatment","volume":"7","author":"Rodriguez","year":"2015","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0045","first-page":"1549","article-title":"Differential permeability of a human brain tumor xenograft in the nude rat: impact of tumor size and method of administration on optimizing delivery of biologically diverse agents","volume":"4","author":"Neuwelt","year":"1998","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/A:1006379332212","article-title":"Phase II studies of RMP-7 and carboplatin in the treatment of recurrent high grade glioma. RMP-7 European Study Group","volume":"44","author":"Gregor","year":"1999","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0055","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/neuonc\/5.2.96","article-title":"A randomized, double-blind, placebo controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma","volume":"5","author":"Prados","year":"2003","journal-title":"Neuro-Onco"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1010683128853","article-title":"Superselective intra-arterial carboplatin for treatment of intracranial neoplasms: experience in 100 procedures, J","volume":"51","author":"Qureshi","year":"2001","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11060-010-0124-x","article-title":"Bradykinin increases the permeability of the blood-tumor barrier by the caveolae-mediated transcellular pathway","volume":"99","author":"Liu","year":"2010","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainres.2007.01.133","article-title":"Bradykinin-induced blood-brain tumor barrier permeability increase is mediated by adenosine 5\u2032-triphosphate-sensitive potassium channel","volume":"1144","author":"Zhang","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00006123-199607000-00025","article-title":"Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7","volume":"39","author":"Matsukado","year":"1996","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0080","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0361-9230(03)00043-1","article-title":"Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from Bradykinin receptor agonist, Cereport","volume":"60","author":"Borlongan","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0085","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0006-8993(95)01143-9","article-title":"Pathway across bloodbrain barrier opened by the bradykinin agonist, RMP-7","volume":"705","author":"Sanovich","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/neuonc\/5.2.96","article-title":"A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma","volume":"5","author":"Prados","year":"2003","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.colsurfb.2011.09.048","article-title":"Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier","volume":"90","author":"Kuo","year":"2012","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/10430349950019093","article-title":"Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasms","volume":"10","author":"Rainov","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0105","first-page":"871","article-title":"Effect of angiotensin II on liposome uptake by the rat brain in vivo","volume":"37","author":"Das","year":"1999","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jconrel.2012.09.007","article-title":"Ultrasound-mediated blood-brain\/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model","volume":"163","author":"Park","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0115","article-title":"Safe long-term repeated disruption of the blood-brain barrier using an implantable ultrasound device : a multiparametric study in primates","author":"Horodyckid","year":"2015","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0120","first-page":"12","article-title":"Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications","volume":"24","author":"Hynynen","year":"2005","journal-title":"Neuro Image"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0125","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1088\/0031-9155\/55\/18\/001","article-title":"The impact of standing wave effects on transcranial focused ultrasound disruption of the blood-brain barrier in a rat model","volume":"55","author":"O'Reilly","year":"2010","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.addr.2014.01.008","article-title":"Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system","volume":"0","author":"Aryal","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0135","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.3171\/2014.12.FOCUS14758","article-title":"Therapeutic strategies to improve drug delivery across the blood-brain barrier","volume":"38","author":"Azad","year":"2015","journal-title":"Neurosurg. Focus."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0140","doi-asserted-by":"crossref","first-page":"e58995","DOI":"10.1371\/journal.pone.0058995","article-title":"Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study","volume":"8","author":"Wei","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0145","doi-asserted-by":"crossref","first-page":"871","DOI":"10.7863\/jum.2009.28.7.871","article-title":"Experimental study on targeted methotrexate delivery to the rabbit brain via magnetic resonance imaging-guided focused ultrasound","volume":"28","author":"Mei","year":"2009","journal-title":"J. Ultrasound Med."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2012.08.012","article-title":"Focused ultrasound for targeted delivery of siRNA and efficient knockdown of Htt expression","volume":"163","author":"Burgess","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0155","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1158\/0008-5472.CAN-12-2609","article-title":"Focused ultrasound delivers targeted immune cells to metastatic brain tumors","volume":"73","author":"Alkins","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0160","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jconrel.2014.06.031","article-title":"Non-invasive delivery of stealth, brain-enetrating nanoparticles across the blood-brain barrier using MRI-guided focused ultrasound","volume":"189","author":"Nance","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jconrel.2013.04.007","article-title":"Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model","volume":"169","author":"Aryal","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0170","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.nano.2013.12.006","article-title":"Focused ultrasound delivery of Raman nanoparticles across the blood brain barrier: potential for targeting experimental brain tumors","volume":"10","author":"Diaz","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0175","doi-asserted-by":"crossref","first-page":"O20","DOI":"10.1186\/2050-5736-3-S1-O20","article-title":"Ultrasound-targeted nanoparticle delivery across the blood-brain barrier","volume":"3","author":"Price","year":"2015","journal-title":"J Ther. Ultrasound"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0180","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3171\/jns.1954.11.5.0471","article-title":"Production of focal destructive lesions in the central nervous system with ultrasound","volume":"11","author":"Fry","year":"1954","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0185","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s00330-007-0644-8","article-title":"Thermal ablation of uterine fibroids using MR-guided focused ultrasound-a truly non-invasive treatment modality","volume":"17","author":"Chapman","year":"2007","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/annonc\/mdl335","article-title":"MR-guided focused ultrasound surgery (MRgFUS) for the palliation of pain in patients with bone metastases\u2013preliminary clinical experience","volume":"18","author":"Catane","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0195","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/j.1471-4159.1990.tb03128.x","volume":"55","author":"Begley","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0200","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0022-3565(25)10451-5","article-title":"Cerebrospinal fluid transport and disposition of the quinolones ciprofloxacin and pefloxacin in rats","volume":"263","author":"Jaehde","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0205","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0006-8993(99)02089-2","article-title":"Comparison of cytosine arabinoside delivery to rat brain by i.v, intrathecal, intraventricular and intraparenchymal routes of administration","volume":"856","author":"Groothuis","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0210","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.brainres.2004.12.007","article-title":"Distribution in brain liposomes after convection enhanced delivery; modulation by particle charge, particle diameter and presence of steric coating","volume":"1035","author":"MacKay","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0215","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1021\/js9601602","article-title":"Controlled release of proteins to tissue transplants for treatments of neurodegenerative disorders","volume":"85","author":"Mahoney","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0220","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0166-2236(98)01261-2","article-title":"Extracellular space structure revealed by diffusion analysis","volume":"21","author":"Nicholson","year":"1998","journal-title":"Trends Neuro. Sci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0225","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jneumeth.2015.11.008","article-title":"Chronic, intermittent convection-enhanced delivery devices","volume":"259","author":"Lewis","year":"2016","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0230","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/neuonc\/nou354","article-title":"Convection-enhanced delivery for the treatment of glioblastoma","volume":"17","author":"Vogelbaum","year":"2015","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0235","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jocn.2011.01.012","article-title":"Neurosurgical convection-enhanced delivery of treatments for Parkinson's disease","volume":"18","author":"Lam","year":"2011","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0240","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2017.06.028","article-title":"Liposomal temozolomide drug delivery using convection enhanced delivery","volume":"261","author":"Nordling-David","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0245","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nurt.2007.10.064","article-title":"Image-guided convection-enhanced delivery platform in the treatment of neurological diseases","volume":"5","author":"Fiandaca","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0250","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jconrel.2016.04.006","article-title":"Distribution of polymer nanoparticles by convection-enhanced delivery to brain tumors","volume":"23","author":"Saucier-Sawyer","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0255","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3171\/jns.1991.74.3.0441","article-title":"Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas","volume":"74","author":"Brem","year":"1991","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0260","doi-asserted-by":"crossref","first-page":"721","DOI":"10.6004\/jnccn.2005.0042","article-title":"Local treatment of malignant brain tumors using implantable chemotherapeutic polymers","volume":"3","author":"Gallia","year":"2005","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0265","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0169-409X(02)00054-6","article-title":"Local drug delivery to the brain","volume":"54","author":"Wang","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0270","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1185\/03007990802611935","article-title":"Localized BCNU chemotherapy and the multimodal management of malignant glioma","volume":"25","author":"La Rocca","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0275","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jconrel.2006.03.012","article-title":"Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles","volume":"112","author":"Kawano","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0280","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/wnan.93","article-title":"Microchips and controlled-release drug reservoirs","volume":"2","author":"Staples","year":"2010","journal-title":"WIREs Nanomed. Nanobiotech."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0285","doi-asserted-by":"crossref","DOI":"10.3109\/10717544.2014.903579","article-title":"Implantable microchip: the futuristic controlled drug delivery system","volume":"23","author":"Sutradhar","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0290","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1016\/j.biomaterials.2012.04.048","article-title":"Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model","volume":"33","author":"Masi","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0295","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2007.08.003","article-title":"Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model","volume":"123","author":"Kim","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0300","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.pharmtox.47.120505.105237","article-title":"Drug targeting to the brain","volume":"47","author":"De Boer","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0305","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijpharm.2012.05.038","article-title":"Enhanced brain accumulation of pazopanib by modulating P-gp and Bcrp1 mediated efflux with canertinib or erlotinib","volume":"436","author":"Minocha","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0310","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/dmd.113.056176","article-title":"Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?","volume":"42","author":"Callaghan","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0315","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tips.2005.11.009","article-title":"Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs","volume":"27","author":"Breedveld","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0320","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejps.2009.02.018","article-title":"Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles","volume":"37","author":"Song","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0325","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2009.01.021","article-title":"Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance","volume":"136","author":"Patil","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0330","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijpharm.2011.05.082","article-title":"Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes","volume":"416","author":"Patel","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0335","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/10717544.2012.724473","article-title":"Long-circulating PEG-PE micelles coloaded with paclitaxel and elacridar (GG918) overcome multidrug resistance","volume":"19","author":"Sarisozen","year":"2012","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0340","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/138945011795378540","article-title":"Improving cancer chemotherapy with modulators of ABC drug transporters","volume":"12","author":"Shukla","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0345","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.2174\/138161211798194486","article-title":"Prodrugs and endogenous transporters: are they suitable tools for drug targeting into the central nervous system?","volume":"17","author":"Pavan","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0350","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.arabjc.2013.12.008","article-title":"Design, synthesis, chemical and biological evaluation of brain targeted alkylating agent using reversible redox prodrug approach","volume":"10","author":"Singh","year":"2017","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0355","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1021\/jm970715l","article-title":"Strategies to target kyotorphin analogues to the brain","volume":"41","author":"Chen","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0360","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1021\/jm701175d","article-title":"Large neutral amino acid transporter enables brain drug delivery via prodrugs","volume":"51","author":"Gynther","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0365","doi-asserted-by":"crossref","first-page":"22","DOI":"10.14312\/2052-4994.2014-4","article-title":"Stem cells' guided gene therapy of cancer: new frontier in personalized and targeted therapy","volume":"2","author":"Mavroudi","year":"2014","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0370","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.it.2012.07.004","article-title":"Capture, crawl, cross: the T cell code to breach the bloodbrain barriers","volume":"33","author":"Engelhardt","year":"2012","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0375","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/13550280902769764","article-title":"Acquired immunodeficiency syndrome and the bloodbrain barrier","volume":"15","author":"Ivey","year":"2009","journal-title":"J. NeuroVirol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0380","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11060-010-0511-3","article-title":"Photothermal treatment of glioma; an in vitro study of macrophage-mediated delivery of gold nanoshells","volume":"104","author":"Baek","year":"2011","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0385","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbcan.2014.04.005","article-title":"Comprehensive overview of exosomes as drug delivery vehicles endogenous nanocarriers for targeted cancer therapy","volume":"1846","author":"Johnsen","year":"2014","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0390","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/hmg\/10.19.2109","article-title":"Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery","volume":"10","author":"Mazarakis","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0395","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.nbd.2005.01.022","article-title":"A novel peptide defined through phage display for therapeutic protein and vector neuronal targeting","volume":"19","author":"Liu","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0400","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/WCO.0b013e328359b0bc","article-title":"Epidermal growth factor receptor: a re-emerging target in glioblastoma","volume":"25","author":"Hegi","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0405","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1227\/01.NEU.0000345646.85472.EA","article-title":"Antitumor treatment using interleukin-12- secreting marrow stromal cells in an invasive glioma model","volume":"64","author":"Hong","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0410","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.addr.2011.06.010","article-title":"Mesenchymal stem cells engineered for cancer therapy","volume":"64","author":"Shah","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0415","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2174\/156652309789753347","article-title":"Stem cells as delivery vehicles for oncolytic adenoviral virotherapy","volume":"9","author":"Kranzler","year":"2009","journal-title":"Curr. Gene. Ther."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0420","doi-asserted-by":"crossref","first-page":"dju090","DOI":"10.1093\/jnci\/dju090","article-title":"Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy","volume":"106","author":"Duebgen","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0425","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.biomaterials.2007.06.011","article-title":"Active targeting of brain tumors using nanocarriers","volume":"28","author":"B\u00e9duneau","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0430","doi-asserted-by":"crossref","first-page":"6878","DOI":"10.1038\/srep06878","article-title":"Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: sequential delivery of doxorubicin and Bcl-2 siRNA","volume":"4","author":"Yoon","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0435","first-page":"5995","article-title":"Investigation of enzyme-sensitive lipid nanoparticles for delivery of siRNA to blood-brain barrier and glioma cells","volume":"10","author":"Bruun","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0440","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2012.09.054","article-title":"Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies","volume":"439","author":"Martins","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0445","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3109\/1061186X.2011.651726","article-title":"Nano-sized cationic polymeric magnetic liposomes significantly improve drug delivery to the brain in rats","volume":"20","author":"Zhao","year":"2012","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0450","doi-asserted-by":"crossref","first-page":"82331","DOI":"10.1371\/journal.pone.0082331","article-title":"Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)","volume":"9","author":"Gaillard","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0455","doi-asserted-by":"crossref","first-page":"14164","DOI":"10.1073\/pnas.93.24.14164","article-title":"Brain drug delivery of small molecules using Immunoliposomes","volume":"93","author":"Huwyler","year":"1996","journal-title":"PNAS"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0460","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/088800199277452","article-title":"Liposomal daunorubicin (DaunoXome) in children with recurrent or progressive brain tumors","volume":"16","author":"Ippens","year":"1999","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0465","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.1073\/pnas.1117412109","article-title":"Molecular MRI enables early and sensitive detection of brain metastases","volume":"109","author":"Serres","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0470","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1016\/j.biomaterials.2011.12.046","article-title":"The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model","volume":"33","author":"Dilnawaz","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0475","first-page":"76","article-title":"Strategic drug delivery targeted to the brain: a review","volume":"3","author":"Roy","year":"2012","journal-title":"Der Pharmac. Sin."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0480","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/archotol.1979.00790160014003","volume":"105","author":"Jackson","year":"1979","journal-title":"Arch. Otolaryngol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0485","first-page":"94","volume":"2","author":"Sanjay","year":"2011","journal-title":"Der Pharmac. Sin."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0490","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2217\/fnl.14.15","article-title":"Time to open the blood\u2013brain barrier gate for biologics?","volume":"9","author":"Freskg\u00e5rd","year":"2015","journal-title":"Future Neurol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0495","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrn2995","article-title":"Engaging neuroscience to advance translational research in brain barrier biology","volume":"12","author":"Neuwelt","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0500","unstructured":"Alz forum. AD monoclonals. http:\/\/www.alzforum.org\/news\/conferencecoverage\/aducanumab-solanezumab-gantenerumab-data-lift-crenezumab-well August 10 (2015)."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0505","first-page":"1460","article-title":"Alzheimer's disease cooperative study data, A. & publication, C. phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease","volume":"370","author":"Doody","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0510","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuropharm.2016.03.014","article-title":"Antibody therapies in CNS diseases","volume":"120","author":"Freskg\u00e5rd","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0515","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJM200304173481614","article-title":"Natalizumab for relapsing multiple sclerosis","volume":"348","author":"Chaudhuri","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0520","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1212\/WNL.0000000000000125","article-title":"Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: a phase 2 study","volume":"82","author":"Sorensen","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0525","author":"Roche"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0530","author":"Roche"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0535","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1124\/jpet.111.183483","article-title":"Exposure levels of anti-LINGO-1 Li81 antibody in the central nervous system and dose-efficacy relationships in rat spinal cord remyelination models after systemic administration","volume":"339","author":"Pepinsky","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0540","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nm1664","article-title":"LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis","volume":"13","author":"Mi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0545","first-page":"149","article-title":"Tumor and T cell engagement by BiTE","volume":"16","author":"Wickramasinghe","year":"2013","journal-title":"Discov. Med."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0550","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002230","article-title":"Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target","volume":"3","author":"Yu","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2016.09.019","article-title":"Camelid single-domain antibodies: a versatile tool for in vivo imaging of extracellular and intracellular brain targets","volume":"243","author":"Tengfei","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0560","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pneurobio.2016.08.001","article-title":"Lipocalin-2 as a therapeutic target for brain injury: an astrocentric perspective","volume":"144","author":"Kyoungho","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0565","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.phrs.2016.06.031","article-title":"HMGB1 as biomarker and drug target","volume":"111","author":"Venereau","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0570","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13324","article-title":"Mfsd2a is critical for the formation and function of the blood\u2013brain barrier","volume":"509","author":"Ben-Zvi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0575","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature13241","article-title":"Mfsd2a is a transporter for the essential omega-3 fatty aciddocosahexaenoic acid","volume":"509","author":"Nguyen","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0580","unstructured":"C. Gu, A. Ben-Zvi, Modulating or treating permeability of blood\u2013brain barrierby administering inhibitor of gene, or agonist of gene, or gene expressionproduct e.g. major facilitator superfamily domain-containing protein 2(Mfsd2A) to human, Harvard College (Hard-C), p. 131. Internationalapplication number: PCT\/US2014\/043395, International publication number: WO 2014\/205338 A2."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0585","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ng.3348","article-title":"Lipid transport and human brain development","volume":"47","author":"Betsholtz","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0590","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1517\/14728222.2015.1042364","article-title":"Blood\u2013brain barrier endogenous transporters astherapeutic targets: a new model for small molecule CNS drug discovery","volume":"19","author":"Pardridge","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0595","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s11095-012-0966-3","article-title":"Design, synthesis and brain uptake of LAT1-targeted aminoacid prodrugs of dopamine","volume":"30","author":"Peura","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0600","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.colsurfb.2015.04.049","article-title":"Targeting of AIDS relatedencephalopathy using phenylalanine anchored lipidic nanocarrier","volume":"131","author":"Vyas","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0605","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2017.05.001","article-title":"A strategy for bypassing the blood-brain barrier: facial intradermal braintargeted delivery via the trigeminal nerve","volume":"258","author":"Yu","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0610","first-page":"1511","article-title":"Induction of cell death in a glioblastoma line by hyperthermic therapy based on gold nanorods","volume":"7","author":"Fernandez","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0615","doi-asserted-by":"crossref","first-page":"9256","DOI":"10.1073\/pnas.1018790108","article-title":"Minimally invasive molecular delivery into the brain using optical modulation of vascular permeability","volume":"108","author":"Choi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0620","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0006-8993(95)00637-6","article-title":"Quantitative analysis of the olfactory path-way for drug delivery to the brain","volume":"692","author":"Thorne","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0625","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0361-9230(85)90129-7","article-title":"Transport of molecules from nose to brain: Transneuronal anterograde and retrograde labeling in the rat olfactory system by wheat germ agglutinin-horseradish peroxidase applied to the nasal epithelium","volume":"15","author":"Shipley","year":"1985","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0630","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0635","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1007\/s11095-012-0915-1","article-title":"Intranasal treatment of central nervous system dysfunction in human","volume":"30","author":"Chapman","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0640","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1288\/00005537-198811000-00015","article-title":"The relationship between nasal anatomy and human olfaction","volume":"98","author":"Leopold","year":"1988","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0645","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0896-6273(94)90351-4","article-title":"Globose basal cells are neuronal progenitors in the olfactory epithelium: a lineage analysis using a replication-incompetent retrovirus","volume":"13","author":"Caggiano","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0650","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neubiorev.2006.01.002","article-title":"Olfactory\/trigeminal interactions in nasal chemoreception","volume":"30","author":"Brand","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0655","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/02688690701447420","article-title":"CSF pathways: a review","volume":"21","author":"Brodbelt","year":"2007","journal-title":"Br. J. Neurosurg."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0660","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/000348946006900210","article-title":"Electron microscopy of the olfactory and gustatory pathways","volume":"68","author":"Lorenzo","year":"1960","journal-title":"Ann. Otol. Rhinolaryngol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0665","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/mp100029t","article-title":"Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures","volume":"7","author":"Johnson","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0670","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-i to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0675","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1517\/17425247.2013.790887","article-title":"Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting","volume":"10","author":"Pardeshi","year":"2013","journal-title":"Expert Opin. Drug. Deliv."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0680","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrm1786","article-title":"Life of a clathrin coated: insight from clathrin and AP structures","volume":"7","author":"Edeling","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0685","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/bj20031253","article-title":"Size dependent internalization of particles via the pathway of clathrin and caveolae mediated endocytosis","volume":"377","author":"Rejman","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0690","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2007.10.046","article-title":"Gateways and tools for drug delivery: endocytic pathway and the cellular dynamics of cell penetrating peptides","volume":"354","author":"Jones","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0695","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.physiol.68.040104.131404","article-title":"Claudins and epithelial paracellular transport","volume":"68","author":"Van Itallie","year":"2006","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0700","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0378-5173(01)00797-9","article-title":"Effect of poly\u2013L-arginine on the nasal absorption of FTIR-dextran of different molecular weights and recombinant human granulocyte colony stimulating factor (RHG-SF) in rats","volume":"226","author":"Miyamoto","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0705","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0168-3659(01)00454-0","volume":"76","author":"Yamamoto","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0710","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0169-409X(98)00073-8","article-title":"Intranasal insulin delivery and therapy","volume":"35","author":"Hinchcliffe","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0715","first-page":"94","article-title":"Nasal drug delivery: an approach of drug delivery through nasal route","volume":"2","author":"Dey","year":"2011","journal-title":"Der Pharmac. Sin."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0720","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.resp.2012.12.005","article-title":"Modeling of release position and ventilation effects on olfactory aerosol drug delivery","volume":"186","author":"Si","year":"2013","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0725","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.psyneuen.2012.11.019","article-title":"Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human, research","volume":"38","author":"Guastella","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0730","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0378-5173(98)00367-6","article-title":"Evaluation of the clearance characteristics of bioadhesive systems in humans","volume":"178","author":"Soane","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0735","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0169-409X(97)00059-8","article-title":"Nasal mucociliary clearance as a factor in nasal drug delivery","volume":"29","author":"Merkus","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0740","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0006-3002(58)90166-5","article-title":"Activity of insulin degraded by leucine aminopeptidase","volume":"29","author":"Smith","year":"1958","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0745","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0169-409X(89)90018-5","article-title":"Penetration and enzymatic barriers to peptide and protein absorption","volume":"4","author":"Lee","year":"1990","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0750","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/194589240301700208","article-title":"The four components of the nasal valve","volume":"17","author":"Cole","year":"2003","journal-title":"Am. J. Rhinol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0755","first-page":"331","article-title":"Recent progress in protein and peptide delivery by non-invasive routes","volume":"8","author":"Wearly","year":"1991","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0760","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000054460","article-title":"Brain potential and attention after acute subchronic intranasal administration of ACTH4-10 desacetyl-a-MSH in human","volume":"70","author":"Smolnik","year":"1999","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0765","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-510X(01)00532-9","article-title":"Intranasal administration of insulin like growth factor-I bypass the blood brain barrier and protects against focal cerebral ischemic damage","volume":"187","author":"Liu","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0770","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejcb.2009.02.001","article-title":"Intranasal delivery of cells to brain","volume":"88","author":"Danielyan","year":"2009","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0775","doi-asserted-by":"crossref","first-page":"866","DOI":"10.5966\/sctm.2012-0045","article-title":"Intranasal delivery of neural stem\/progenitor cells: a non-invasive passage to target intracerebral gioma","volume":"1","author":"Reitz","year":"2012","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0780","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/mt.2013.199","article-title":"Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors","volume":"22","author":"Balyasnikova","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0785","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4236\/jct.2011.21003","article-title":"Case of advanced recurrent glioblastoma successfully treated with monoterpene perillyl alcohol by intranasal administration","volume":"2","author":"Fonseca","year":"2011","journal-title":"J. Cancer Ther."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0790","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1523\/JNEUROSCI.4905-07.2008","article-title":"Systemic vesicular stomatitis virus selectively destroys multifocal glioma and metastatic carcinoma in brain","volume":"28","author":"Ozduman","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0795","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1021\/mp900275s","article-title":"Intranasal delivery of methotrexate to brain tumors in rat: new strategy for brain tumor chemotherapy","volume":"7","author":"Shingaki","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0800","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1215\/15228517-2007-052","article-title":"New therapeutic approach for brain tumors: intranasal delivery of telomerase inhibitor GRN163","volume":"10","author":"Hashizume","year":"2008","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0805","article-title":"Temozolomide-perillyl alcohol conjugate induced reactive oxygen species accumulation contributes to its cytotoxicity against non-small cell lung cancer","volume":"6","author":"Song","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0810","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1158\/1535-7163.MCT-13-0882","article-title":"A novel temozolomide-perillyl alcohol conjugate exhibits superior activity against breast cancer cells in vitro and intracranial triple-negative tumor growth in vivo","volume":"13","author":"Chen","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0815","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","article-title":"Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype","volume":"27","author":"Reger","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0820","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-2008-13309","article-title":"Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults","volume":"13","author":"Reger","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0825","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biopsych.2009.09.020","article-title":"Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders","volume":"67","author":"Guastella","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0830","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awn193","article-title":"Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1)","volume":"131","author":"Baier","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0835","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/en.2011-1586","article-title":"Intranasal leptin reduces appetite and induces weight loss in rats with diet-induced obesity (DIO)","volume":"153","author":"Schulz","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0840","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1210\/en.2005-1016","article-title":"Brain uptake of intranasally applied radioiodinated leptin in Wistar rats","volume":"47","author":"Fliedner","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0845","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/088307380201700206","article-title":"Effects of intranasal midazolam and rectal diazepam on acute convulsions in children: prospective randomized study","volume":"17","author":"Fi\u015fgin","year":"2002","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0850","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1528-1167.2009.02333.x","article-title":"A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations","volume":"51","author":"Haan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0855","first-page":"221","article-title":"Best evidence topic report. Intranasal naloxone in suspected opioid overdose","volume":"23","author":"Ashton","year":"2006","journal-title":"Emerg Med"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0860","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1158\/1535-7163.MCT-12-0321","article-title":"Perillyl alcohol for the treatment of temozolomide-resistant gliomas","volume":"11","author":"Cho","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0865","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery\u2013possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0870","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2174\/156720106777731019","article-title":"Liposomes and micro\/nanoparticles as colloidal carriers for nasal drug delivery","volume":"3","author":"Mainardes","year":"2006","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0875","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jps.20718","article-title":"Nanoparticle systems for nasal delivery of drugs: a real improvement over simple systems?","volume":"96","author":"Illum","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0880","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijpharm.2007.07.035","article-title":"In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery","volume":"349","author":"Chen","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0885","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1002\/jps.21335","article-title":"Brain uptake of an anti-ischemic agent by nasal administration of microparticles","volume":"97","author":"Dalpiaz","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0890","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ejps.2005.04.015","article-title":"Nanoparticles across an in vitro model of the human follicle associated epithelium","volume":"25","author":"Des Rieux","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0895","first-page":"298","article-title":"Microsphere transport pathways in the rabbit nasal mucosa","volume":"1","author":"Huang","year":"1996","journal-title":"Int. J. Pharm. Adv."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0900","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejpb.2012.04.007","article-title":"Chitosan-based drug delivery systems","volume":"81","author":"Bernkop-Schnurch","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0905","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jconrel.2012.03.017","article-title":"Chitosan-based drug nanocarriers: where do we stand?","volume":"161","author":"Garcia-Fuentes","year":"2012","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2017.09.001_bb0910","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/10717544.2014.907372","article-title":"Brain targeted nanoparticulate drug delivery system of rasagiline via intranasal route","author":"Mittal","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0915","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejps.2012.12.007","article-title":"Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: Pharmacodynamic, pharmacokinetic and scintigraphy study in mice model","volume":"48","author":"Md","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0920","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijpharm.2004.05.009","article-title":"Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy","volume":"280","author":"Tafaghodi","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0925","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymer"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0930","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/jps.23836","article-title":"Nose-to-brain delivery: evaluation of polymeric nanoparticles on olfactory ensheathing cells uptake","volume":"103","author":"Musumeci","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0935","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2011.02.022","article-title":"Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration","volume":"151","author":"Wen","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0940","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/j.biomaterials.2007.04.011","article-title":"Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells","volume":"28","author":"Elfinger","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0945","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.2147\/IJN.S120939","article-title":"Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment","volume":"11","author":"Bi","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0950","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1021\/acs.molpharmaceut.5b00402","article-title":"Brain targeting of a water insoluble antipsychotic drug haloperidol via the intranasal route using PAMAM dendrimers","volume":"12","author":"Katare","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0955","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/mt.2011.291","article-title":"Intranasal delivery of HMGB1 siRNA confers target gene knockdown and robust neuroprotection in the postischemic brain","volume":"20","author":"Kim","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0960","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.toxlet.2014.04.020","article-title":"Effects of PAMAM dendrimers in the mouse brain after a single intranasal instillation","volume":"228","author":"Win-Shwe","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0965","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.apsb.2016.04.001","article-title":"Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides","volume":"6","author":"Lin","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0970","doi-asserted-by":"crossref","first-page":"9888","DOI":"10.1016\/j.biomaterials.2011.09.004","article-title":"Low molecular weight protamine functionalized nanoparticles for drug delivery to the brain after intranasal administration","volume":"32","author":"Xia","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0975","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2014.11.004","article-title":"Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides","volume":"197","author":"Kamei","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.001_bb0980","first-page":"573","article-title":"Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys","volume":"25","author":"Mattiuz","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0985","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/03639045.2012.758130","article-title":"Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting","volume":"40","author":"Md","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2017.09.001_bb0990","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijpharm.2013.11.049","article-title":"Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease","author":"Zhang","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb0995","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s11095-011-0641-0","article-title":"Nose to brain transport pathway of wheat germ agglutinin conjugated PEG-PLA nanoparticles","volume":"29","author":"Liu","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1000","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s13233-013-1029-2","article-title":"Cell-penetrating peptide-modified PLGA nanoparticles for enhanced nose-to-brain macromolecular delivery","volume":"21","author":"Yan","year":"2013","journal-title":"Macromol. Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejps.2015.07.002","article-title":"Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: effect on formulation and characterization parameters","volume":"78","author":"Shah","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1010","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.nano.2013.10.009","article-title":"Gelatin nanostructured lipid carriers-mediated intranasal delivery of basic fibroblast growth factor enhances functional recovery in hemiparkinsonian rats","volume":"10","author":"Zhao","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00180-1","article-title":"Nanostructured lipid matrices for improved microencapsulation of drugs","volume":"242","author":"M\u00fcller","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.colsurfb.2014.06.037","article-title":"Surface engineered nanostructured lipid carriers for efficient nose to brain delivery of ondansetron HCl using Delonix regia gum as a natural mucoadhesive polymer","volume":"122","author":"Devkar","year":"2014","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1025","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.colsurfb.2015.06.054","article-title":"Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration","volume":"134","author":"Gartziandia","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1030","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1021\/mp5008376","article-title":"Comparative biodistribution and pharmacokinetic analysis of cyclosporine-A in the brain upon intranasal or intravenous administration in an oil-in-water nanoemulsion formulation","volume":"2","author":"Yadav","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1035","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.jconrel.2015.05.014","article-title":"W\/O nanoemulsion-based intranasal drug delivery system of Panax notoginseng saponins for brain targeting","volume":"213","author":"Ding","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1040","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.colsurfb.2013.09.030","article-title":"Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment","volume":"113","author":"Sood","year":"2014","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1045","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.nano.2015.12.374","article-title":"Intranasal brain delivery of cationic nanoemulsion-encapsulated TNF\u03b1 siRNA in prevention of experimental neuroinflammation","volume":"12","author":"Yadav","year":"2016","journal-title":"Nanomed. Nanotechnol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1050","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2174\/1567201813666151202195729","article-title":"Nanoemulsions for intranasal delivery of riluzole to improve brain bioavailability: formulation development and pharmacokinetic studies","volume":"13","author":"Parikh","year":"2016","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1055","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s11095-009-0041-x","article-title":"Micellar nanocarriers: potential nose-to-brain delivery of zolmitriptan as novel migraine therapy","volume":"27","author":"Jain","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1060","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1007\/s11095-011-0440-7","article-title":"Cell penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration","volume":"28","author":"Kanazawa","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1065","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1016\/j.biomaterials.2013.08.036","article-title":"Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles","volume":"34","author":"Kanazawa","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1070","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/ph5101092","article-title":"Intranasal delivery of \u2013loaded Tat-modified nanomicells for treatment of intracranial brain tumors","volume":"5","author":"Taki","year":"2012","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1075","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jddst.2015.08.003","article-title":"Formulation and evaluation of thermoreversible mucoadhesive in-situ gel for intranasal delivery of naratriptan hydrochloride","volume":"29","author":"Shelke","year":"2015","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1080","first-page":"1373","article-title":"Increased brain radioactivity by intranasal P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels","volume":"7","author":"Perez","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1085","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.colsurfb.2016.08.011","article-title":"Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery","volume":"147","author":"Hao","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/10611860903386938","article-title":"Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats","volume":"18","author":"Khan","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1095","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3109\/1061186X.2011.558090","article-title":"Nose-to-brain transport of melatonin from polymer gel suspensions: a microdialysis study in rats","volume":"19","author":"Babu","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1100","first-page":"65","article-title":"Liposomes as targetable drug carriers","volume":"2","author":"Torchilin","year":"1985","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1110","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1007\/s11095-015-1744-9","article-title":"Intranasal H102 peptide loaded liposomes for brain delivery to treat Alzheimer's disease","volume":"32","author":"Zheng","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.lfs.2016.08.033","article-title":"Development of risperidone liposomes for brain targeting through intranasal route","volume":"163","author":"Narayan","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/2210303106666160120215857","article-title":"Xanthan gum coated mucoadhesive liposomes for efficient nose to brain delivery of curcumin","volume":"5","author":"Samudre","year":"2016","journal-title":"Drug Deliv. Lett."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1125","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijpharm.2013.05.009","article-title":"Enhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administration","volume":"452","author":"Yang","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/08982104.2011.592495","article-title":"Development and evaluation of tripalmitin emulsomes for the treatment of experimental visceral leishmaniasis","volume":"22","author":"Pal","year":"2012","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1135","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2009.06.026","article-title":"Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate","volume":"380","author":"Paliwal","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1140","first-page":"192","article-title":"Emulsomes: a novel liposoomal formulation for sustained drug delivery","volume":"3","author":"Aswathy","year":"2013","journal-title":"Int. Res. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijpharm.2016.02.038","article-title":"Identifying lipidic emulsomes for improved oxcarbazepine brain targeting: in vitro and rat in vivo studies","volume":"503","author":"El-Zaafarany","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1150","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejpb.2012.10.010","article-title":"Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting","volume":"0","author":"Gavini","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1155","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.actbio.2016.05.037","article-title":"Enhanced cell survival of pH-sensitive bioenergetic nucleotide nanoparticles in energy\/oxygen-depleted cells and their intranasal delivery for reduced brain infarction","volume":"41","author":"Choi","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1160","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/archneurol.2011.2945","article-title":"Alterations in brain transition metals in Huntington disease: an evolving and intricate story","volume":"69","author":"Rosas","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1165","doi-asserted-by":"crossref","first-page":"e77023","DOI":"10.1371\/journal.pone.0077023","article-title":"Iron accumulates in Huntington's disease neurons: protection by deferoxamine","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1170","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1460-9568.2009.06701.x","article-title":"Fenton, chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease","volume":"29","author":"Rival","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1175","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.brainres.2014.05.048","article-title":"Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinson's disease","volume":"1574","author":"Fine","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1180","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2015.01.025","article-title":"Solid microparticles based on chitosan or methyl-\u03b2-cycl-odextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate","volume":"201","author":"Rassu","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1185","first-page":"109","article-title":"Evaluation of brain targeting for the nasal delivery of midazolam","volume":"12","author":"Desai","year":"2012","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1190","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ijpharm.2012.10.049","article-title":"Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting","volume":"441","author":"Jose","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1195","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijpharm.2016.09.042","article-title":"Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery","volume":"513","author":"Lungare","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1200","first-page":"300","article-title":"Brain targeting of olanzapine via intranasal delivery of core\u2013shell difunctional block copolymer mixed nanomicellar carriers: in vitro characterization, ex vivo estimation of nasal toxicity and in vivo biodistribution studies","volume":"452","author":"Abdelbary","year":"2013","journal-title":"Pharm. Nanotech."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1205","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/03639040802363704","article-title":"Formulation and characterization of nanoemulsion based drug delivery system of risperidone","volume":"35","author":"Kumar","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1210","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.carbpol.2012.02.051","article-title":"Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation","volume":"89","author":"Haque","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1215","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/10717544.2012.657720","article-title":"Delivery of growth differentiation factor 5 to the central nervous system","volume":"19","author":"Hanson","year":"2012","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1220","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1166\/asl.2010.1149","article-title":"Preparation and evaluation of microemulsion based formulation for rapid onset intranasal delivery of zonisamide","volume":"3","author":"Shahiwala","year":"2010","journal-title":"Adv. Sci. Lett."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1225","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2174\/1567201812666150507120124","article-title":"Nose to brain delivery of midazolam loaded PLGA nanoparticles: in vitro and in vivo investigations","volume":"13","author":"Sharma","year":"2016","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1230","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2008.03.029","article-title":"Intranasal nanoemulsion based brain targeting drug delivery system of risperidone","volume":"358","author":"Kumar","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1235","first-page":"363","article-title":"Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model","volume":"6","author":"Eskandari","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1240","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejpb.2008.07.005","article-title":"Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting","volume":"70","author":"Wang","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1245","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","article-title":"Intranasal insulin improves memory in humans","volume":"29","author":"Benedict","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1250","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.nano.2012.11.004","article-title":"Curcumin-conjugated nanoliposomes with high affinity for A\u03b2 deposits: possible applications to Alzheimer disease","volume":"9","author":"Laza","year":"2013","journal-title":"Nanomed. Nanotechnol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1255","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.colsurfb.2017.03.035","article-title":"Nose to brain delivery in rats: effect of surface charge of rhodamine B labeled nanocarriers on brain subregion localization","volume":"1","author":"Bonaccorso","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1260","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/1061186021000001823","article-title":"Visualization of in vivo olfactory uptake and transfer using fluorescein dextran","volume":"10","author":"Jansson","year":"2002","journal-title":"J. Drug Target."},{"issue":"9","key":"10.1016\/j.jconrel.2017.09.001_bb1265","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1007\/s11095-011-0440-7","article-title":"Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration","volume":"28","author":"Kanazawa","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1270","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1023\/A:1016444808000","article-title":"Chitosans as absorption enhancers for poorly absorbable drugs. 1: influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells","volume":"13","author":"Schipper","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1275","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-5173(97)04914-4","article-title":"The effect of chronic nasal application of chitosan solutions on cilia beat frequency in guinea pigs","volume":"153","author":"Aspden","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1280","first-page":"882","article-title":"Intranasal toxicity of selected absorption enhancers","volume":"56","author":"Haffejee","year":"2001","journal-title":"Pharmazie"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1285","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1002\/jps.22528","article-title":"Upregulation of endogenous neurotrophin levels in the brain by intranasal administration of carnosic acid","volume":"100","author":"Vaka","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1290","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.carbpol.2013.08.027","article-title":"Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats","volume":"99","author":"Bshara","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1295","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2010.08.020","article-title":"Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution","volume":"400","author":"Vllasaliu","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1300","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1517\/17425247.2014.894504","article-title":"Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC\/mass spectrometry method","volume":"11","author":"Md","year":"2014","journal-title":"Expert Opin. Drug. Deliv."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1305","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1016\/j.biomaterials.2006.01.038","article-title":"Lectin-conjugated PEG\u2013PLA nanoparticles: preparation and brain delivery after intranasal administration","volume":"27","author":"Gao","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1310","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.tox.2009.09.016","article-title":"Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling","volume":"265","author":"Kilk","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1315","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.molmed.2012.04.012","article-title":"Cell-penetrating peptides: breaking through to the other side","volume":"18","author":"Koren","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1320","first-page":"243","article-title":"Nanocarriers as novel nose-to-brain targeted drug delivery platforms","volume":"4","author":"Patel","year":"2012","journal-title":"Indian J. Nov. Drug Deliv"},{"issue":"16","key":"10.1016\/j.jconrel.2017.09.001_bb1325","article-title":"Brain targeting of olanzapine via intranasal delivery of core-shell difunctional block copolymer mixed nanomicellar carriers: in-vitro characterization, ex-vivo estimation of nasal toxicity and in-vivo biodistribution studies","volume":"452","author":"Abdelbary","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1330","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jsps.2016.07.003","article-title":"Direct and enhanced delivery of nanoliposomes of anti schizophrenic agent to the brain through nasal rout","volume":"25","author":"Upadhyay","year":"2017","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1335","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jddst.2015.05.002","article-title":"Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review","author":"Rassu","year":"2016","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1340","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1023\/A:1011933410898","article-title":"Comparison of nasal deposition and clearance of aerosol generated by nebulizer and an aqueous spray pump","volume":"16","author":"Suman","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1345","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/jam.2004.17.249","article-title":"Bi-directional nasal delivery of aerosols can prevent lung deposition","volume":"17","author":"Djupesland","year":"2004","journal-title":"J. Aerosol. Med."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1350","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s13346-012-0108-9","article-title":"Nasal drug delivery devices: characteristics and performance in a clinical perspective\u2014a review","volume":"3","author":"Djupesland","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1355","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4155\/tde.14.41","article-title":"Nasal approach to delivering treatment for brain disease: an anatomic, physiologic and delivery technology overview","volume":"5","author":"Djupesland","year":"2014","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1360","author":"Optinose"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1365","doi-asserted-by":"crossref","first-page":"e602","DOI":"10.1038\/tp.2015.93","article-title":"Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment","volume":"5","author":"Quintana","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1370","author":"Optinose"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1375","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3109\/03639045.2016.1160110","article-title":"Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort\u00ae device and formulation","volume":"42","author":"Pozzoli","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1380","unstructured":"Platform technology. http:\/\/www.SNBL.com."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1385","first-page":"22","article-title":"Meeting the needs for nasal delivery devices for powder formulations","volume":"12","author":"Haruta","year":"2012","journal-title":"Drug Dev. Deliv."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1390","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2008.11.009","article-title":"Development and testing of particulate formulations for the nasal delivery of antibodies","volume":"135","author":"Kaye","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1395","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.vaccine.2004.06.049","article-title":"A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats","volume":"23","author":"Huanga","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1400","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1517\/17425247.4.6.689","article-title":"Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance","volume":"4","author":"Berger","year":"2007","journal-title":"Expert Opin. Drug. Deliv."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1405","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1365-2222.2000.00695.x","article-title":"Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400\u03bcg once daily and twice daily in the treatment of bilateral nasal polyposis: a placebo-controlled randomized study in adult patients","volume":"30","author":"Penttil\u00e4","year":"2000","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1410","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00405-006-0071-5","article-title":"Influence of anatomy and head position on intranasal drug deposition","volume":"263","author":"Merkus","year":"2006","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1415","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0169-409X(97)00067-7","article-title":"Nasal delivery systems and their effect on deposition and absorption","volume":"29","author":"Vidgren","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1420","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.otohns.2003.07.005","article-title":"Safety review of benzalkonium chloride used as a preservative in intranasal solutions: an overview of conflicting data and opinions","volume":"130","author":"Marple","year":"2004","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1425","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1111\/j.1526-4610.2006.00603.x","article-title":"Nasal delivery of antimigraine drugs: clinical rationale and evidence base","volume":"46","author":"Rapoport","year":"2006","journal-title":"Headache"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1430","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2500\/aap.2012.33.3565","article-title":"Medical costs and adherence in patients receiving aqueous versus pressurized aerosol formulations of intranasal corticosteroids","volume":"33","author":"Hankin","year":"2012","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1435","first-page":"78","article-title":"How to use pressurised metered dose inhalers","volume":"47","author":"Heslop","year":"2008","journal-title":"Nurs Times, 104"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1440","first-page":"83","article-title":"Comparative morphometry of the nasal cavity in rats and mice","volume":"135","author":"Gross","year":"1982","journal-title":"J. Anat."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.902970102","article-title":"Morphology of the human olfactory epithelium","volume":"297","author":"Morrison","year":"1990","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1450","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1213\/ANE.0b013e3182239b8c","article-title":"Enhanced analgesic responses after preferential delivery of morphine and fentanyl to the olfactory epithelium in rats","volume":"113","author":"Hoekman","year":"2011","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1455","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/npp.2014.61","article-title":"Intranasal delivery of a peptide with antidepressant-like effect","volume":"39","author":"Brown","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1460","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1208\/s12249-011-9614-1","article-title":"Effects of localized hydrophilic mannitol and hydrophobic nelfinavir administration targeted to olfactory epithelium on brain distribution","volume":"12","author":"Hoekman","year":"2011","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1465","series-title":"Nasal drug Delivery Device, WOO2012119153 A2","author":"Hoekman","year":"2012"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1470","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1023\/A:1011933410898","article-title":"Comparison of nasal deposition and clearance of aerosol generated by nebulizer and an aqueous spray pump","volume":"16","author":"Suman","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1475","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4193\/Rhino10.268","article-title":"Nasally inhaled pulsating aerosols: lung, sinus and nose deposition","volume":"49","author":"Moller","year":"2011","journal-title":"Rhinology"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1480","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3390\/ijms17091463","article-title":"Perillyl alcohol and its drug-conjugated derivatives as potential novel methods of treating brain metastases","volume":"17","author":"Chen","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1485","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1089\/jam.2007.0569","article-title":"Devices for aerosol delivery to treat sinusitis","volume":"20","author":"Laul","year":"2007","journal-title":"J. Aerosol. Med."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1490","series-title":"Controlled Particle Dispersion. Effective Nasal Delivery from a Versatile, Flexible delivery Platform","first-page":"13","author":"Giroux","year":"2005"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1495","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1500","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","article-title":"Intranasal insulin improves cognition and modulates beta-amyloid in early AD","volume":"70","author":"Djupesland","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1505","unstructured":"C.C. Wolf, Nosy neuroprotection: intranasal administration of neuroprotective agents to the brain, Cryonics Magazine, 28 18\u201320."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1510","article-title":"Nasal and olfactory deposition with normal and bidirectional intranasal delivery techniques: in vitro tests and numerical simulations","author":"Jinxiang","year":"2016","journal-title":"J. Aerosol. Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1515","doi-asserted-by":"crossref","first-page":"O11","DOI":"10.1186\/1753-6561-9-S9-O11","article-title":"Protein aerosol for intranasal nose to brain (N2B) delivery","volume":"9","author":"St\u00fctzle","year":"2015","journal-title":"BMC Proc."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1520","series-title":"Nasal Drug Delivery Device, US 20140014104","author":"Hoekman","year":"2014"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1525","series-title":"Nasal Drug Delivery Device, CN103917265 A","author":"Hoekman","year":"2014"},{"key":"10.1016\/j.jconrel.2017.09.001_bb1530","unstructured":"Q. Mingxin, H.E. Renyang, S.H.I. Junwei, Brain-Targeted Nasal Drug Delivery Device and Body Position Fixator Thereof\", WIPO Patent WO\/2015\/127857."},{"key":"10.1016\/j.jconrel.2017.09.001_bb1535","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10717544.2013.838713","article-title":"Insights into direct nose to brain delivery: current status and future perspective","volume":"21","author":"Mittal","year":"2014","journal-title":"Drug Deliv."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917308258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917308258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T15:58:34Z","timestamp":1750867114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917308258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":307,"alternative-id":["S0168365917308258"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.09.001","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress in brain targeting drug delivery system by nasal route","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}